These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21165951)

  • 1. Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin.
    Lu WJ; Lee NP; Kaul SC; Lan F; Poon RT; Wadhwa R; Luk JM
    Int J Cancer; 2011 Oct; 129(8):1806-14. PubMed ID: 21165951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
    Lu WJ; Lee NP; Kaul SC; Lan F; Poon RT; Wadhwa R; Luk JM
    Cell Death Differ; 2011 Jun; 18(6):1046-56. PubMed ID: 21233847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition.
    Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Huang M; Deng YR; Li JS
    Int J Oncol; 2014 Jan; 44(1):247-55. PubMed ID: 24190572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico analysis of the binding properties of solasonine to mortalin and p53, and in vitro pharmacological studies of its apoptotic and cytotoxic effects on human HepG2 and Hep3b hepatocellular carcinoma cells.
    Pham MQ; Tran THV; Pham QL; Gairin JE
    Fundam Clin Pharmacol; 2019 Aug; 33(4):385-396. PubMed ID: 30628118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
    Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
    J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines.
    Gestl EE; Anne Böttger S
    Biochem Biophys Res Commun; 2012 Jun; 423(2):411-6. PubMed ID: 22683628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of HSP70-2 expression by RNA interference induces apoptosis of human hepatocellular carcinoma cells].
    Xia LM; Tian DA; Zhang Q; Yan W; Wang B; Liu M; Li PY; Chen B
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):678-82. PubMed ID: 18822209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.
    Wadhwa R; Takano S; Kaur K; Deocaris CC; Pereira-Smith OM; Reddel RR; Kaul SC
    Int J Cancer; 2006 Jun; 118(12):2973-80. PubMed ID: 16425258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
    Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
    Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 and hepatocellular carcinoma.
    Puisieux A; Ozturk M
    Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
    Ahronian LG; Driscoll DR; Klimstra DS; Lewis BC
    PLoS One; 2015; 10(4):e0123816. PubMed ID: 25885474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
    Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
    Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma.
    Lim SO; Kim H; Jung G
    FEBS Lett; 2010 Jun; 584(11):2231-6. PubMed ID: 20385133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mortalin detected in human liver cancer by tissue microarrays.
    Chen X; Xu B; Li H; Yang L; Zuo J; Liu W; Liu C
    Anat Rec (Hoboken); 2011 Aug; 294(8):1344-51. PubMed ID: 21714113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249.
    Shi H; Lambert JM; Hautefeuille A; Bykov VJ; Wiman KG; Hainaut P; Caron de Fromentel C
    Carcinogenesis; 2008 Jul; 29(7):1428-34. PubMed ID: 18048389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and role of SIRT1 in hepatocellular carcinoma.
    Choi HN; Bae JS; Jamiyandorj U; Noh SJ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Oncol Rep; 2011 Aug; 26(2):503-10. PubMed ID: 21567102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
    Wadhwa R; Takano S; Taira K; Kaul SC
    J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepatocellular carcinoma HepG2 cells.
    Zhu Q; Xu YM; Wang LF; Zhang Y; Wang F; Zhao J; Jia LT; Zhang WG; Yang AG
    Cancer Biol Ther; 2009 May; 8(9):792-8. PubMed ID: 19270509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.